Form 4: Health Catalyst CCO Sells Shares for Tax Obligations

Health Catalyst's Chief Commercial Officer, Kevin Lee Freeman, sold 16,401 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Kevin Lee Freeman, Chief Commercial Officer of Health Catalyst, Inc. (HCAT), reported a disposition of common stock.
• The transaction occurred on December 1, 2025, involving 16,401 shares of common stock.
• The shares were sold at a price of $2.9002 per share.
• This sale was mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations for vested Restricted Stock Units (RSUs) and was not a discretionary trade.
• Following this transaction, Kevin Lee Freeman beneficially owns 358,686 shares of common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a mandatory 'sell to cover' for tax purposes related to RSU vesting, which is a routine and non-discretionary event for executives. It does not indicate a positive or negative sentiment towards the company's prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units.
• This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This insider transaction is a routine, company-specific event related to executive compensation and tax obligations, and does not reflect broader industry trends or competitive dynamics within the healthcare technology sector.

Stakeholder Impact

• Shareholders: The transaction is a routine, non-discretionary sale for tax purposes and is unlikely to have a significant impact on shareholder perception or the company's operational performance.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Health Catalyst, HCAT, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Chief Commercial Officer